Loading …

We currently market GLP-1 /GIP agonist medications in the Nigerian pharmaceutical space and through our Venture company B-CLASSIC VENTURES LTD we hope to become the global's standard for innovative, AI enhanced drug discovery and development
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.